165 related articles for article (PubMed ID: 32970375)
21. Retrospective review of the effects of rhDNase in children with cystic fibrosis.
Davies J; Trindade MT; Wallis C; Rosenthal M; Crawford O; Bush A
Pediatr Pulmonol; 1997 Apr; 23(4):243-8. PubMed ID: 9141109
[TBL] [Abstract][Full Text] [Related]
22. Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes.
Collaco JM; Green DM; Cutting GR; Naughton KM; Mogayzel PJ
Am J Respir Crit Care Med; 2010 Nov; 182(9):1137-43. PubMed ID: 20581166
[TBL] [Abstract][Full Text] [Related]
23. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
Sanders DB; Solomon GM; Beckett VV; West NE; Daines CL; Heltshe SL; VanDevanter DR; Spahr JE; Gibson RL; Nick JA; Marshall BC; Flume PA; Goss CH;
J Cyst Fibros; 2017 Sep; 16(5):592-599. PubMed ID: 28460885
[TBL] [Abstract][Full Text] [Related]
24. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
[TBL] [Abstract][Full Text] [Related]
25. Antibiotics and outcomes of CF pulmonary exacerbations in children infected with MRSA and Pseudomonas aeruginosa.
Cogen JD; Hall M; Faino AV; Ambroggio L; Blaschke AJ; Brogan TV; Cotter JM; Gibson RL; Grijalva CG; Hersh AL; Lipsett SC; Shah SS; Shapiro DJ; Neuman MI; Gerber JS
J Cyst Fibros; 2023 Mar; 22(2):313-319. PubMed ID: 35945130
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria.
Castner LM; Zimbric M; Cahalan S; Powell C; Caverly LJ
J Cyst Fibros; 2021 Nov; 20(6):926-931. PubMed ID: 33612403
[TBL] [Abstract][Full Text] [Related]
27. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
[TBL] [Abstract][Full Text] [Related]
28. Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
Cogen JD; Faino AV; Onchiri F; Hoffman LR; Kronman MP; Nichols DP; Rosenfeld M; Gibson RL
Clin Infect Dis; 2021 Nov; 73(9):1589-1596. PubMed ID: 34100912
[TBL] [Abstract][Full Text] [Related]
29. Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbations.
Faino AV; Hoffman LR; Gibson RL; Kronman MP; Nichols DP; Rosenfeld M; Cogen JD
J Cyst Fibros; 2023 Jul; 22(4):630-635. PubMed ID: 36849332
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis.
Blanchard AC; Shaw M; Ratjen F; Tullis E; Daneman N; Waters V
J Cyst Fibros; 2023 Sep; 22(5):880-883. PubMed ID: 37474423
[TBL] [Abstract][Full Text] [Related]
31. The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis.
VanDevanter EJ; Heltshe SL; Skalland M; Lechtzin N; Nichols D; Goss CH
J Cyst Fibros; 2021 Nov; 20(6):932-936. PubMed ID: 33685776
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
Regelmann WE; Schechter MS; Wagener JS; Morgan WJ; Pasta DJ; Elkin EP; Konstan MW;
Pediatr Pulmonol; 2013 Jul; 48(7):649-57. PubMed ID: 22949088
[TBL] [Abstract][Full Text] [Related]
33. Course of Illness after Viral Infection in Indian Children with Cystic Fibrosis.
Gulla KM; Balaji A; Mukherjee A; Jat KR; Sankar J; Lodha R; Kabra SK
J Trop Pediatr; 2019 Apr; 65(2):176-182. PubMed ID: 29893951
[TBL] [Abstract][Full Text] [Related]
34. Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.
Cogen JD; Faino AV; Onchiri F; Gibson RL; Hoffman LR; Kronman MP; Rosenfeld M; Nichols DP
Ann Am Thorac Soc; 2021 Feb; 18(2):266-272. PubMed ID: 32810412
[No Abstract] [Full Text] [Related]
35. Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis.
McElvaney OJ; Heltshe SL; Odem-Davis K; West NE; Sanders DB; Fogarty B; VanDevanter DR; Flume PA; Goss CH
Ann Am Thorac Soc; 2024 May; 21(5):716-726. PubMed ID: 38096105
[No Abstract] [Full Text] [Related]
36. Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network.
Lau JS; Kiss C; Roberts E; Horne K; Korman TM; Woolley I
Ann Clin Microbiol Antimicrob; 2017 Jan; 16(1):3. PubMed ID: 28100229
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.
Sanders DB; Bittner RC; Rosenfeld M; Redding GJ; Goss CH
Pediatr Pulmonol; 2011 Apr; 46(4):393-400. PubMed ID: 20967845
[TBL] [Abstract][Full Text] [Related]
38. Association of Inhaled Antibiotics in Addition to Standard Intravenous Therapy and Outcomes of Pediatric Inpatient Pulmonary Exacerbations.
Cogen JD; Faino AV; Onchiri F; Hoffman LR; Kronman MP; Nelson M; Nichols DP; Rosenfeld M; VanDevanter DR; Gibson RL
Ann Am Thorac Soc; 2020 Dec; 17(12):1590-1598. PubMed ID: 32726564
[No Abstract] [Full Text] [Related]
39. Poor recovery from cystic fibrosis pulmonary exacerbations is associated with poor long-term outcomes.
Sanders DB; Zhao Q; Li Z; Farrell PM
Pediatr Pulmonol; 2017 Oct; 52(10):1268-1275. PubMed ID: 28881091
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of azithromycin in patients with cystic fibrosis.
Samson C; Tamalet A; Thien HV; Taytard J; Perisson C; Nathan N; Clement A; Boelle PY; Corvol H
Respir Med; 2016 Aug; 117():1-6. PubMed ID: 27492507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]